Online inquiry

IVTScrip™ mRNA-Human ARHGAP29, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28593MR)

This product GTTS-WK28593MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGAP29 protein. This product can be used in MKI67+ progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001328664.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9411
UniProt ID Q52LW3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP29, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28593MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK11671MR IVTScrip™ mRNA-Human ADRM1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADRM1
GTTS-WK21692MR IVTScrip™ mRNA-Human ARHGAP28, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP28
GTTS-WK11639MR IVTScrip™ mRNA-Human ADGRE5, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADGRE5
GTTS-WK12533MR IVTScrip™ mRNA-Human ADGRB2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRB2
GTTS-WK18231MR IVTScrip™ mRNA-Human ANKRD54, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD54
GTTS-WK17010MR IVTScrip™ mRNA-Human ANKRD20A9P, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD20A9P
GTTS-WK24379MR IVTScrip™ mRNA-Human ARGLU1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARGLU1
GTTS-WK28586MR IVTScrip™ mRNA-Human ARHGAP20, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP20
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW